tiprankstipranks

GB:MRN3 ETF Technical Analysis

Compare

Summary of all the Indicators

Summary
Strong Sell
3Bullish
5Neutral
14Bearish
Oscillators
Sell
2Bullish
5Neutral
3Bearish
Moving Averages
Strong Sell
1Bullish
0Neutral
11Bearish
Leverage Shares 3x Long Moderna (MRNA) ETP Securities’s (MRN3) Moving Averages Convergence Divergence (MACD) indicator is -0.02, suggesting Leverage Shares 3x Long Moderna (MRNA) ETP Securities is a Sell.
Leverage Shares 3x Long Moderna (MRNA) ETP Securities’s (MRN3) 20-Day exponential moving average is 0.08, making it a Sell.
Leverage Shares 3x Long Moderna (MRNA) ETP Securities’s (MRN3) 50-Day exponential moving average is 0.22, making it a Sell.

Leverage Shares 3x Long Moderna (MRNA) ETP Securities (MRN3) Pivot Points

Feb 23, 2025, 09:09 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.04
0.05
0.06
0.06
0.07
0.08
0.08
Fibonacci
0.05
0.06
0.06
0.06
0.07
0.07
0.08

Leverage Shares 3x Long Moderna (MRNA) ETP Securities (MRN3) Moving Averages

Feb 23, 2025, 09:09 PM
Period
Simple
Exponential
MA5
0.06Sell
0.06Sell
MA10
0.06Buy
0.06Sell
MA20
0.08Sell
0.08Sell
MA50
0.14Sell
0.22Sell
MA100
0.32Sell
1.23Sell
MA200
6.11Sell
5.52Sell
Leverage Shares 3x Long Moderna (MRNA) ETP Securities’s (MRN3) 10-Day exponential moving average is 0.06, making it a Sell.
Leverage Shares 3x Long Moderna (MRNA) ETP Securities’s (MRN3) 100-Day exponential moving average is 1.23, making it a Sell.
Leverage Shares 3x Long Moderna (MRNA) ETP Securities’s (MRN3) 50-day simple moving average is 0.14, creating a Sell signal.
Leverage Shares 3x Long Moderna (MRNA) ETP Securities’s (MRN3) 100-day simple moving average is 0.32, creating a Sell signal.
Leverage Shares 3x Long Moderna (MRNA) ETP Securities’s (MRN3) 200-day simple moving average is 6.11, creating a Sell signal.

Leverage Shares 3x Long Moderna (MRNA) ETP Securities (MRN3) Technical Analysis

Feb 23, 2025, 09:09 PM
Name
Value
Action
RSI (14)
39.20
Neutral
STOCH (9,6)
67.59
Neutral
STOCHRSI (14)
36.06
Neutral
MACD (12,26)
-0.02
Sell
ADX (14)
10.78
Buy
Williams %R
-55.32
Buy
CCI (14)
-48.48
Neutral
ATR (14)
0.02
-
Ultimate Oscillator
59.75
Neutral
ROC
-25.00
Sell
Leverage Shares 3x Long Moderna (MRNA) ETP Securities’s (MRN3) Relative Strength Index (RSI) is 39.20, creating a Neutral signal.
Leverage Shares 3x Long Moderna (MRNA) ETP Securities’s (MRN3) Trend Strength Indicator (ADX) is 10.78, creating a Buy signal.
Leverage Shares 3x Long Moderna (MRNA) ETP Securities’s (MRN3) Commodity Channel Index (CCI) is -48.48, creating a Neutral signal.
Leverage Shares 3x Long Moderna (MRNA) ETP Securities’s (MRN3) Price Rate of Change (ROC) is -25.00, creating a Sell signal.

FAQ

Is MRN3 a Buy, Hold, or Sell?
Based on MRN3’s technical indicators, MRN3 is a Strong Sell.
    What is MRN3’s RSI (14)?
    MRN3’s RSI (14) is 39.20, which suggests MRN3 is a Neutral.
      What is MRN3’s MACD?
      MRN3’s MACD is -0.02, which suggests MRN3 is a Sell.
        What is MRN3’s 5-day moving average?
        MRN3’s 5-day moving average is 0.06, which suggests MRN3 is a Sell.
          What is MRN3’s 20-day moving average?
          MRN3 20-day moving average is 0.08, which suggests MRN3 is a Sell.
            What is MRN3’s 50-day moving average?
            MRN3’s 50-day moving average is 0.14, which suggests MRN3 is a Sell.
              What is MRN3’s 200-day moving average?
              MRN3’s 200-day moving average is 6.11, which suggests MRN3 is a Sell.
                What is MRN3’s Williams % R (14)?
                MRN3’s Williams % R (14) is -55.32, which suggests MRN3 is a Buy.
                  What is MRN3’s CCI (14)?
                  MRN3’s CCI (14) is -48.48, which suggests MRN3 is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis